Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

SYRESpyre Therapeutics, Inc.

Nasdaq · CIK 0001636282
Filer categoryLarge accelerated filer
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts350

Identity from submissions API

NameSpyre Therapeutics, Inc.
CIK0001636282
TickersSYRE
ExchangesNasdaq
Entity typeoperating
CategoryLarge accelerated filer
SIC2834 Pharmaceutical Preparations
EIN464312787
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone6176515940
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Aeglea BioTherapeutics, Inc. (2015-03-24T04:00:00.000Z → 2023-11-24T05:00:00.000Z)
Business address
221 CRESCENT STREET
BUILDING 23, SUITE 105
WALTHAM
MA
02453
MA
Mailing address
221 CRESCENT STREET
BUILDING 23, SUITE 105
WALTHAM
MA
02453
MA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

823 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-03 8-K 8-K 2.02,9.01 0001636282-26-000132 001-37722 261517221 34 294619 1 1
2026-11-03 10-Q 10-Q 0001636282-26-000131 001-37722 261517186 34 10511851 1 1
2026-10-09 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-115087 005-89456 261453548 34 19375
2026-10-07 8-K 8-K 1.01,9.01 0001628280-26-065291 001-37722 261445485 34 590973 1 1
2026-10-06 424B5 424B5 0001628280-26-065249 333-297063 261444591 33 809056 1 1
2026-10-05 424B5 424B5 0001628280-26-064924 333-297063 261440477 33 659285
2026-10-02 4 FORM 4 0001636282-26-000119 16875
2026-10-02 4 FORM 4 0001636282-26-000118 14798
2026-10-02 4 FORM 4 0001636282-26-000117 22415
2026-10-01 144 xsl144X01/primary_doc.xml 0001950047-26-009978 001-37722 261431956 33 6438
2026-10-01 144 xsl144X01/primary_doc.xml 0001950047-26-009971 001-37722 261431811 33 6774
2026-10-01 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-112828 005-89456 261431350 34 16628
2026-09-30 144 xsl144X01/primary_doc.xml 0001950047-26-009876 001-37722 261427157 33 7910
2026-09-08 8-K 8-K 7.01,8.01,9.01 0001636282-26-000113 001-37722 261363444 34 237732 1 1
2026-09-03 4 FORM 4 0001636282-26-000111 20156
2026-09-03 4 FORM 4 0001636282-26-000109 17161
2026-09-03 4 FORM 4 0001636282-26-000107 11454
2026-09-01 144 xsl144X01/primary_doc.xml 0001950047-26-008970 001-37722 261351613 33 5155
2026-08-25 8-K 8-K 7.01,8.01,9.01 0001636282-26-000105 001-37722 261315697 34 225629 1 1
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-352655 005-89456 261283808 34 11143
2026-08-14 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001493215-26-000157 005-89456 261276297 34 10628
2026-08-10 4 FORM 4 0001636282-26-000102 13205
2026-08-07 144 xsl144X01/primary_doc.xml 0001950047-26-007821 001-37722 261254950 33 4902
2026-08-07 144 xsl144X01/primary_doc.xml 0001950047-26-007819 001-37722 261254946 33 4898
2026-08-05 4 FORM 4 0001636282-26-000100 13064
2026-08-05 4 FORM 4 0001636282-26-000099 13353
2026-08-04 8-K 8-K 2.02,9.01 0001636282-26-000098 001-37722 261238560 34 290669 1 1
2026-08-04 10-Q 10-Q 0001636282-26-000096 001-37722 261238397 34 10496021 1 1
2026-08-03 144 xsl144X01/primary_doc.xml 0001950047-26-007571 001-37722 261233918 33 7284
2026-07-02 4 FORM 4 0001636282-26-000088 11663
2026-07-02 4 FORM 4 0001636282-26-000087 11133
2026-07-02 4 FORM 4 0001636282-26-000086 9554
2026-07-01 144 xsl144X01/primary_doc.xml 0001950047-26-006779 001-37722 261146318 33 6440
2026-06-26 4 FORM 4 0001853327-26-000008 10923
2026-06-26 S-3ASR S-3ASR 0001628280-26-045742 333-297063 261129020 33 1405491 1 1
2026-06-25 144 xsl144X01/primary_doc.xml 0001950047-26-006485 001-37722 261121854 33 7149
2026-06-23 144 xsl144X01/primary_doc.xml 0001104659-26-076969 001-37722 261112874 33 6313
2026-06-23 4 OWNERSHIP DOCUMENT 0001104659-26-076967 19148
2026-06-23 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-076961 005-89456 261112852 34 19236
2026-06-23 4 FORM 4 0001636282-26-000084 4891
2026-06-22 144 xsl144X01/primary_doc.xml 0001950047-26-006375 001-37722 261107693 33 5872
2026-06-15 8-K 8-K 7.01,8.01,9.01 0001636282-26-000083 001-37722 261089093 34 220518 1 1
2026-06-03 4 FORM 4 0001636282-26-000078 8763
2026-06-03 4 FORM 4 0001636282-26-000077 9554
2026-06-03 4 FORM 4 0001636282-26-000076 13523
2026-06-03 144 xsl144X01/primary_doc.xml 0001950047-26-005572 001-37722 261061067 33 6551
2026-06-01 8-K 8-K 8.01,9.01 0001636282-26-000075 001-37722 261050399 34 190429 1 1
2026-05-29 4 FORM 4 0001636282-26-000069 10222
2026-05-29 4 FORM 4 0001636282-26-000068 5759
2026-05-29 4 FORM 4 0001636282-26-000067 5732
2026-05-29 4 FORM 4 0001636282-26-000066 5745
2026-05-29 4 FORM 4 0001636282-26-000065 5729
2026-05-29 4 FORM 4 0001859810-26-000002 5738
2026-05-29 8-K 8-K 5.02,5.07,9.01 0001636282-26-000056 001-37722 261045514 34 345462 1 1
2026-05-08 4 FORM 4 0001636282-26-000053 10981
2026-05-08 144 xsl144X01/primary_doc.xml 0001950047-26-004262 001-37722 26958727 33 5088
2026-05-05 8-K 8-K 2.02,9.01 0001636282-26-000051 001-37722 26940526 34 278103 1 1
2026-05-05 10-Q 10-Q 0001636282-26-000050 001-37722 26940510 34 10639142 1 1
2026-05-01 4 FORM 4 0001853327-26-000005 9298
2026-05-01 4 FORM 4 0002038798-26-000004 19964
2026-05-01 4 FORM 4 0001758363-26-000009 15256
2026-05-01 144 xsl144X01/primary_doc.xml 0001950047-26-003923 001-37722 26933422 33 5708
2026-05-01 144 xsl144X01/primary_doc.xml 0001950047-26-003922 001-37722 26933420 33 6746
2026-04-22 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-170304 005-89456 26883604 34 595393
2026-04-20 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001104659-26-045578 005-89456 26876284 34 19751
2026-04-16 8-K 8-K 1.01,9.01 0001628280-26-025508 001-37722 26867750 34 558501 1 1
2026-04-16 424B5 424B5 0001628280-26-025310 333-293600 26865088 33 528869
2026-04-13 424B5 424B5 0001628280-26-024940 333-293600 26858607 33 522828
2026-04-13 8-K 8-K 2.02,8.01 0001628280-26-024906 001-37722 26858095 34 155496 1 1
2026-04-13 8-K 8-K 7.01,8.01,9.01 0001628280-26-024831 001-37722 26856478 34 4846568 1 1
2026-04-10 ARS ARS 0001636282-26-000043 001-37722 26854993 34 125660354
2026-04-10 DEFA14A DEFA14A 0001636282-26-000041 001-37722 26854827 34 502995
2026-04-10 DEF 14A DEF 14A 0001636282-26-000039 001-37722 26854759 34 5199192 1 1
2026-04-03 4 FORM 4 0001758363-26-000007 7654
2026-04-03 4 FORM 4 0001636282-26-000030 8673
2026-04-03 4 FORM 4 0001853327-26-000003 11662
2026-04-01 144 xsl144X01/primary_doc.xml 0001950047-26-003140 001-37722 26828900 33 4927
2026-03-27 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000102909-26-002337 005-89456 26804591 34 7462
2026-03-04 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000722 333-285341 26724019 33 1895
2026-03-03 4 FORM 4 0001636282-26-000028 11524
2026-03-03 4 FORM 4 0001636282-26-000026 7516
2026-03-03 144 xsl144X01/primary_doc.xml 0001950047-26-002111 001-37722 26715498 33 5138
2026-03-02 144 xsl144X01/primary_doc.xml 0001950047-26-001983 001-37722 26708275 33 6832
2026-02-27 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000695 333-293600 26703155 33 1882
2026-02-27 POS AM POS AM 0001628280-26-012785 333-285341 26699471 33 30045
2026-02-25 CORRESP filename1.htm 0001628280-26-011614 9442
2026-02-25 UPLOAD filename1.pdf 0000000000-26-001931 333-293600 40261
2026-02-19 S-3 S-3 0001628280-26-009814 333-293600 26654988 33 1078686 1 1
2026-02-19 S-8 S-8 0001636282-26-000024 333-293589 26654519 33 258827 1 1
2026-02-19 8-K 8-K 2.02,9.01 0001636282-26-000022 001-37722 26654346 34 294028 1 1
2026-02-19 10-K 10-K 0001636282-26-000020 001-37722 26654198 34 17902651 1 1
2026-02-17 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-26-002024 005-89456 26641469 34 14324
2026-02-04 4 FORM 4 0001758363-26-000005 7727
2026-01-23 4 FORM 4 0001779990-26-000002 4814
2026-01-13 4 FORM 4 0001636282-26-000004 5610
2026-01-13 4 FORM 4 0001636282-26-000003 5608
2026-01-13 4 FORM 4 0001636282-26-000002 5573
2026-01-13 4 FORM 4 0001636282-26-000001 5631
2026-01-12 8-K 8-K 7.01,9.01 0001193125-26-009894 001-37722 26524890 34 16092960 1 1
2026-01-06 4 FORM 4 0001758363-26-000002 9423
2025-12-03 4 FORM 4 0001758363-25-000003 7524
2025-11-05 4 FORM 4 0001636282-25-000106 7525
2025-11-04 8-K 8-K 2.02,7.01,8.01,9.01 0001636282-25-000104 001-37722 251449138 34 631016 1 1
2025-11-04 10-Q 10-Q 0001636282-25-000102 001-37722 251448813 34 8492538 1 1
2025-11-03 144 xsl144X01/primary_doc.xml 0001950047-25-008390 001-37722 251444473 33 4992
2025-10-17 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001104659-25-100449 005-89456 251401432 34 30000
2025-10-15 8-K 8-K 1.01,9.01 0001193125-25-240237 001-37722 251394843 34 467171 1 1
2025-10-14 424B5 424B5 0001193125-25-239143 333-285341 251392551 33 450415
2025-10-14 424B5 424B5 0001193125-25-237918 333-285341 251389441 33 478672
2025-10-14 8-K 8-K 2.02 0001193125-25-237904 001-37722 251389416 34 147568 1 1
2025-09-03 4 FORM 4 0001636282-25-000095 6096
2025-08-05 S-8 S-8 0001636282-25-000093 333-289255 251185257 33 265264 1 1
2025-08-05 8-K 8-K 2.02,9.01 0001636282-25-000091 001-37722 251185021 34 362787 1 1
2025-08-05 10-Q 10-Q 0001636282-25-000089 001-37722 251184915 34 9046513 1 1
2025-07-29 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000932471-25-001050 005-89456 251160677 34 6483
2025-07-16 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-002469 005-89456 251128426 34 11110
2025-06-17 8-K 8-K 7.01,8.01,9.01 0001193125-25-141756 001-37722 251051832 34 11335028 1 1
2025-06-02 4 FORM 4 0001636282-25-000069 14429
2025-06-02 4 FORM 4 0001636282-25-000068 5567
2025-06-02 4 FORM 4 0001636282-25-000067 5573
2025-06-02 4 FORM 4 0001636282-25-000066 5581
2025-06-02 4 FORM 4 0001636282-25-000065 5584
2025-06-02 4 FORM 4 0001636282-25-000064 5622
2025-06-02 8-K 8-K 5.07,9.01 0001636282-25-000063 001-37722 251014831 34 162481 1 1
2025-06-02 UPLOAD filename1.pdf 0000000000-25-005782 001-37722 39844
2025-05-21 CORRESP filename1.htm 0001636282-25-000054 71266
2025-05-09 UPLOAD filename1.pdf 0000000000-25-004985 001-37722 44137
2025-05-08 8-K 8-K 2.02,9.01 0001636282-25-000050 001-37722 25925941 34 348483 1 1
2025-05-08 10-Q 10-Q 0001636282-25-000049 001-37722 25925806 34 13147068 1 1
2025-05-01 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001214659-25-006773 005-89456 25903293 34 28264
2025-04-14 ARS ARS 0001636282-25-000040 001-37722 25836506 34 33979645
2025-04-14 DEFA14A DEFA14A 0001636282-25-000039 001-37722 25836470 34 349970
2025-04-14 DEF 14A DEF 14A 0001636282-25-000038 001-37722 25836423 34 4075819 1 1
2025-03-13 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000659 333-281975 25737471 33 1902
2025-03-07 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-000613 333-285341 25721946 33 1889
2025-03-07 POS AM POS AM 0001628280-25-011345 333-281975 25720755 33 25839
2025-03-06 8-K 8-K 4.01,9.01 0001193125-25-048423 001-37722 25715429 34 158416 1 1
2025-03-05 CORRESP filename1.htm 0001628280-25-010520 85000
2025-03-04 UPLOAD filename1.pdf 0000000000-25-002409 333-285341 40310
2025-02-27 S-3 S-3 0001628280-25-008686 333-285341 25679284 33 1515522 1 1
2025-02-27 S-8 S-8 0001636282-25-000024 333-285332 25678928 33 273657 1 1
2025-02-27 8-K 8-K 2.02,9.01 0001636282-25-000022 001-37722 25678736 34 373311 1 1
2025-02-27 10-K 10-K 0001636282-25-000020 001-37722 25678562 34 18192542 1 1
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001415889-25-004231 005-89456 25631547 34 25105
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-021223 005-89456 25628912 34 10918
2025-02-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-020484 005-89456 25623665 34 10380
2025-01-17 4 FORM 4 0001636282-25-000010 5613
2025-01-17 4 FORM 4 0001636282-25-000009 5576
2025-01-17 4 FORM 4 0001636282-25-000008 359099
2025-01-17 4 FORM 4 0001636282-25-000007 5610
2025-01-14 4 FORM 4 0001636282-25-000002 361105
2025-01-13 8-K 8-K 2.02,8.01,9.01 0001193125-25-005015 001-37722 25524917 34 21798709 1 1
2024-11-19 8-K 8-K 1.01,9.01 0001628280-24-048527 001-37722 241477279 34 653738 1 1
2024-11-19 424B5 424B3 0001628280-24-048482 333-281975 241476795 33 544466
2024-11-18 424B5 424B5 0001628280-24-048293 333-281975 241472369 33 565845
2024-11-18 10-Q/A 10-Q/A 0001636282-24-000113 001-37722 241471533 34 8273517 1 1
2024-11-18 10-Q/A 10-Q/A 0001636282-24-000111 001-37722 241471513 34 7719729 1 1
2024-11-18 10-Q/A 10-Q/A 0001636282-24-000109 001-37722 241471478 34 6105451 1 1
2024-11-18 10-K/A 10-K 0001636282-24-000107 001-37722 241471431 34 10779209 1 1
2024-11-18 8-K 8-K 4.02,8.01 0001636282-24-000105 001-37722 241471410 34 197758 1 1
2024-11-14 SC 13G/A SC 13G/A 0001104659-24-119333 005-89456 241464787 34 151338
2024-11-14 SC 13G/A SC 13G/A 0001193125-24-258682 005-89456 241463297 34 60206
2024-11-14 SC 13G/A formsc13ga.htm 0001493152-24-045810 005-89456 241461810 34 87407
2024-11-14 SC 13G/A deeptrack-syre093024a2.htm 0001172661-24-004773 005-89456 241457896 34 103380
2024-11-14 SC 13G/A SPYRE THERAPEUTICS, INC. 0000902664-24-006526 005-89456 241457825 34 59109
2024-11-12 SC 13G/A filing.txt 0000315066-24-002912 005-89456 241444974 34 8392
2024-11-12 8-K 8-K 7.01,8.01,9.01 0001628280-24-046860 001-37722 241443342 34 4750891 1 1
2024-11-08 4 FORM 4 0001636282-24-000089 5451
2024-11-08 SC 13G us00773j2024_110824.txt 0002012383-24-003588 005-89456 241439705 34 13924
2024-11-07 S-8 S-8 0001636282-24-000087 333-283065 241435926 33 284665
2024-11-07 8-K 8-K 2.02,9.01 0001636282-24-000085 001-37722 241435564 34 361312 1 1
2024-11-07 10-Q 10-Q 0001636282-24-000083 001-37722 241435358 34 10163353 1 1
2024-10-28 4 FORM 4 0001636282-24-000070 4921
2024-10-25 144 xsl144X01/primary_doc.xml 0001950047-24-007878 001-37722 241397405 33 4967
2024-10-23 SC 13G SCHEDULE 13G 0001683168-24-007319 005-89456 241388829 34 39387
2024-10-22 SC 13G us00773j2024_102224.txt 0002012383-24-001245 005-89456 241386098 34 13912
2024-10-15 8-K 8-K 1.01,7.01,8.01,9.01 0001193125-24-237150 001-37722 241369027 34 18990971 1 1
2024-10-02 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-10-02 16:15:00 9999999995-24-003068 333-282252 241349719 33 1890
2024-10-01 4 FORM 4 0001636282-24-000068 5671
2024-10-01 3 FORM 3 0001636282-24-000066 319370
2024-09-30 CORRESP filename1.htm 0001628280-24-041574 90721
2024-09-26 UPLOAD filename1.pdf 0000000000-24-010954 333-282252 40208
2024-09-20 S-3 S-3 0001628280-24-041021 333-282252 241313417 33 495451
2024-09-18 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-09-18 16:30:00 9999999995-24-002887 333-281975 241308730 33 1890
2024-09-13 CORRESP filename1.htm 0001628280-24-040360 89918
2024-09-12 UPLOAD filename1.pdf 0000000000-24-010311 333-281975 40204
2024-09-06 S-3 S-3 0001628280-24-039683 333-281975 241284548 33 1496979
2024-09-05 4 FORM 4 0001636282-24-000062 6128
2024-08-08 424B3 424B3 0001193125-24-196209 333-278810 241185690 33 1272650
2024-08-08 8-K/A 8-K 8.01 0001636282-24-000058 001-37722 241185458 34 163475 1 1
2024-08-07 8-K 8-K 2.02,9.01 0001636282-24-000053 001-37722 241184040 34 357824 1 1
2024-08-07 10-Q 10-Q 0001636282-24-000051 001-37722 241183628 34 10453691 1 1
2024-06-10 SC 13G/A filing.txt 0000315066-24-001784 005-89456 241031644 34 8378
2024-05-30 8-K 8-K 7.01 0001193125-24-150395 001-37722 241006004 34 148212 1 1
2024-05-16 4 4 0000950170-24-061084 12509
2024-05-16 4 4 0000950170-24-061083 5464
2024-05-16 4 4 0000950170-24-061082 5513
2024-05-16 4 4 0000950170-24-061085 5458
2024-05-16 4 4 0000950170-24-061080 5475
2024-05-16 3 3 0000950170-24-061074 10481
2024-05-15 424B3 424B3 0001193125-24-139363 333-278810 24950438 33 799725
2024-05-15 8-K 8-K 1.01,5.02,5.03,5.07,7.01,9.01 0001193125-24-138893 001-37722 24947181 34 273146 1 1
2024-05-09 8-K 8-K 2.02,9.01 0001636282-24-000039 001-37722 24930720 34 339649 1 1
2024-05-09 10-Q 10-Q 0001636282-24-000037 001-37722 24930561 34 7273553 1 1
2024-04-29 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-04-29 16:15:00 9999999995-24-001192 333-278810 24893794 33 1889
2024-04-25 CORRESP filename1.htm 0001193125-24-114300 16725
2024-04-25 4 4 0000950170-24-048457 14916
2024-04-25 SC 13D/A SC 13D/A 0001193125-24-114056 005-89456 24877053 34 87285
2024-04-25 8-K 8-K 3.02,9.01 0001193125-24-113954 001-37722 24876687 34 199423 1 1
2024-04-25 UPLOAD filename1.pdf 0000000000-24-004609 333-278810 40453
2024-04-23 SC 13G/A SPYRE THERAPEUTICS INC. 0000902664-24-003035 005-89456 24866251 34 59635
2024-04-19 S-1 S-1 0001193125-24-101185 333-278810 24855378 33 13554199 1 1
2024-04-02 ARS ARS 0001636282-24-000024 001-37722 24814935 34 28526233
2024-04-02 SEC STAFF LETTER filename1.pdf 9999999997-24-001517 333-276251 63930
2024-04-01 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001193125-24-077783,2024-04-01 9999999995-24-000807 333-273769 24812080 33 1902
2024-04-01 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-04-01 16:01:00 9999999995-24-000812 333-276251 24812071 33 1889
2024-04-01 DEF 14A DEF 14A 0001636282-24-000021 001-37722 24809164 34 2744942 1 1
2024-03-28 CORRESP filename1.htm 0001193125-24-080597 13720
2024-03-27 POS AM POS AM 0001193125-24-077783 333-273769 24785196 33 13443105 1 1
2024-03-27 S-1/A S-1/A 0001193125-24-077777 333-276251 24785187 33 13420641 1 1
2024-03-26 CORRESP filename1.htm 0001193125-24-077797 16382
2024-03-20 PRE 14A PRE 14A 0001636282-24-000018 001-37722 24766276 34 2761962 1 1
2024-03-18 424B3 424B3 0001193125-24-070131 333-273769 24759022 33 484207
2024-03-18 8-K 8-K 1.01,3.02,5.03,7.01,9.01 0001193125-24-069693 001-37722 24757006 34 718706 1 1
2024-03-14 CORRESP filename1.htm 0001193125-24-067912 17832
2024-03-14 POS AM POS AM 0001193125-24-067903 333-273769 24750254 33 13402559 1 1
2024-03-14 S-1/A S-1/A 0001193125-24-067885 333-276251 24750181 33 13381404 1 1
2024-03-11 SC 13G/A filing.txt 0000315066-24-001673 005-89456 24736626 34 8386
2024-03-08 UPLOAD filename1.pdf 0000000000-24-002607 333-276251 43584
2024-03-05 POS AM POS AM 0001193125-24-059407 333-273769 24722261 33 13371165 1 1
2024-03-01 CORRESP filename1.htm 0001193125-24-055983 47618
2024-03-01 S-1/A S-1/A 0001193125-24-055961 333-276251 24709921 33 13867468 1 1
2024-03-01 10-K/A 10-K/A 0001636282-24-000010 001-37722 24706756 34 401312 1 1
2024-02-29 S-8 S-8 0001193125-24-053633 333-277542 24704947 33 69706
2024-02-29 8-K 8-K 2.02,9.01 0001636282-24-000007 001-37722 24703816 34 369058 1 1
2024-02-29 10-K 10-K 0001636282-24-000005 001-37722 24703617 34 13009125 1 1
2024-02-20 4 4 0000950170-24-017494 5062
2024-02-16 UPLOAD filename1.pdf 0000000000-24-001873 333-276251 59707
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-024226 005-89456 24641695 34 165872
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023876 005-89456 24639821 34 55044
2024-02-14 SC 13G/A agle13ga.htm 0000935836-24-000203 005-89456 24639378 34 47296
2024-02-14 SC 13G/A SC 13G/A 0001193125-24-036324 005-89456 24638970 34 64742
2024-02-14 SC 13G/A SC 13G/A 0001104659-24-023722 005-89456 24638765 34 99892
2024-02-14 SC 13G/A formsc13ga.htm 0001493152-24-006628 005-89456 24637772 34 87489
2024-02-14 SC 13G/A agle13ga.htm 0000935836-24-000193 005-89456 24637173 34 60774
2024-02-14 SC 13G/A rocksprings-agle123123a1.htm 0001172661-24-001205 005-89456 24635911 34 89265
2024-02-14 SC 13G SPYRE THERAPEUTICS, INC. 0000902664-24-001596 005-89456 24632907 34 62155
2024-02-14 SC 13G/A deeptrack-syre123123a1.htm 0001172661-24-000943 005-89456 24632735 34 105863
2024-02-14 SC 13G SPYRE THERAPEUTICS, INC. 0000902664-24-001536 005-89456 24632196 34 66266
2024-02-13 SC 13G/A SC 13G/A 0001193125-24-034079 005-89456 24630859 34 49168
2024-02-13 SC 13G/A d10979554_13g-a.htm 0000919574-24-001081 005-89456 24630242 34 109275
2024-02-13 SC 13G/A AMENDMENT TO FORM SC 13G 0001999371-24-002149 005-89456 24626950 34 85309
2024-02-13 SC 13G/A polar-syre123123a1.htm 0001172661-24-000761 005-89456 24622994 34 110250
2024-02-12 SC 13G/A filing.txt 0000315066-24-001638 005-89456 24618415 34 8391
2024-02-09 SC 13G filing.txt 0000315066-24-001597 005-89456 24612765 34 8310
2024-02-08 SC 13G/A SYRE_SC13GA2.htm 0001319244-24-000024 005-89456 24609673 34 95940
2024-02-07 424B3 424B3 0001193125-24-025665 333-273769 24601919 33 344020
2024-02-05 4 4 0000950170-24-011369 5479
2024-02-05 3 3 0000950170-24-011360 12344
2024-02-05 8-K 8-K 1.01,5.02,5.03,5.05,9.01 0001193125-24-023462 001-37722 24593964 34 547363 1 1
2024-02-05 S-1/A S-1/A 0001193125-24-023071 333-276251 24593623 33 16567442 1 1
2024-02-02 CORRESP filename1.htm 0001193125-24-023082 93860
2024-02-02 4 4 0000950170-24-010904 5508
2024-02-02 4 4 0000950170-24-010901 5501
2024-02-02 4 4 0000950170-24-010896 5520
2024-01-19 SEC STAFF LETTER filename1.pdf 9999999997-24-000177 65059
2024-01-18 UPLOAD filename1.pdf 0000000000-24-000701 333-276251 83688
2024-01-18 8-K 8-K 3.01 0001193125-24-010226 001-37722 24542161 34 147299 1 1
2023-12-29 SC 13D/A SC 13D/A 0001193125-23-306010 005-89456 231528405 34 118907
2023-12-29 4 4 0000950170-23-073904 22407
2023-12-27 D xslFormDX01/primary_doc.xml 06b 0001209191-23-059745 021-500772 231514494 33 20915
2023-12-22 4 4 0000950170-23-072763 5109
2023-12-22 S-8 S-8 0001193125-23-302201 333-276256 231510637 33 330449
2023-12-22 S-1 S-1 0001193125-23-302158 333-276251 231510307 33 21270364 1 1
2023-12-13 SC 13G SC 13G 0001193125-23-294297 005-89456 231483894 34 67485
2023-12-11 4 4 0000950170-23-069455 15129
2023-12-11 SC 13D/A SC 13D/A 0001193125-23-292713 005-89456 231479027 34 126646
2023-12-08 4/A 4/A 0000950170-23-069048 9734
2023-12-08 424B3 424B3 0001193125-23-291672 333-273769 231475434 33 592615
2023-12-08 3/A 3/A 0000950170-23-069037 4777
2023-12-08 8-K 8-K 1.01,3.02,5.03,7.01,9.01 0001193125-23-291257 001-37722 231474016 34 851494 1 1
2023-12-01 SC 13G formsc13g.htm 0001493152-23-043412 005-89456 231459710 34 95343
2023-11-30 424B3 424B3 0001193125-23-286398 333-273769 231456653 33 223738
2023-11-29 SC 13D/A SC 13D/A 0001193125-23-285257 005-89456 231453179 34 120807
2023-11-28 4 4 0000950170-23-066399 20422
2023-11-28 8-K 8-K 5.02,5.03,7.01,9.01 0001193125-23-283693 001-37722 231441897 34 358391 1 1
2023-11-27 4 4 0000950170-23-066146 5440
2023-11-27 4 4 0000950170-23-066143 5385
2023-11-27 3 3 0000950170-23-066141 12031
2023-11-27 3 3 0000950170-23-066136 10785
2023-11-27 4 4 0000950170-23-066131 9838
2023-11-24 8-K 8-K 5.03,5.07,7.01,9.01 0001193125-23-282424 001-37722 231434870 34 179734 1 1
2023-11-20 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2023-11-20 16:01:00 9999999995-23-003387 333-273769 231424381 33 1744
2023-11-17 CORRESP filename1.htm 0001193125-23-279958 10324
2023-11-15 CORRESP filename1.htm 0001193125-23-277996 42943
2023-11-15 S-1/A S-1/A 0001193125-23-277992 333-273769 231411598 33 6450977
2023-11-15 8-K 8-K 8.01,9.01 0001193125-23-277985 001-37722 231411536 34 798690 1 1
2023-11-14 SC 13G SCHEDULE 13G 0001683168-23-008109 005-89456 231404973 34 46235
2023-11-09 10-Q 10-Q 0001636282-23-000018 001-37722 231392497 34 8182037 1 1
2023-11-09 8-K 8-K 2.02,9.01 0001636282-23-000016 001-37722 231392340 34 290879 1 1
2023-10-27 DEF 14A DEF 14A 0001193125-23-264329 001-37722 231351785 34 1928197
2023-10-26 CORRESP filename1.htm 0001193125-23-264241 70854
2023-10-24 UPLOAD filename1.pdf 0000000000-23-011612 39966
2023-10-24 8-K 8-K 7.01,9.01 0001193125-23-261221 001-37722 231341273 34 14618252 1 1
2023-10-20 UPLOAD filename1.pdf 0000000000-23-011518 43978
2023-10-10 S-1/A S-1/A 0001193125-23-252528 333-273769 231315306 33 3233499
2023-10-10 PRER14A PRER14A 0001193125-23-252525 001-37722 231315301 34 2996787
2023-10-10 8-K 8-K 5.02,8.01,9.01 0001193125-23-252523 001-37722 231315300 34 232674 1 1
2023-10-06 CORRESP filename1.htm 0001193125-23-252530 105563
2023-10-06 CORRESP filename1.htm 0001193125-23-252526 70243
2023-10-05 8-K 8-K 1.01 0001193125-23-251664 001-37722 231312138 34 152061 1 1
2023-09-29 UPLOAD filename1.pdf 0000000000-23-010855 43749
2023-09-25 8-K 8-K 1.01,3.01,5.02,9.01 0001193125-23-241316 001-37722 231275841 34 233007 1 1
2023-09-08 CORRESP filename1.htm 0001193125-23-231678 35682
2023-09-08 8-K 8-K 3.03,5.03,7.01,8.01,9.01 0001193125-23-231646 001-37722 231246029 34 7261290 1 1
2023-09-05 4 4 0000950170-23-046396 5467
2023-09-05 3 3 0000950170-23-046385 6605
2023-09-05 4 4 0000950170-23-046384 5439
2023-09-05 3 3 0000950170-23-046380 6596
2023-09-05 8-K 8-K 5.02,8.01,9.01 0001193125-23-228076 001-37722 231234118 34 327914 1 1
2023-08-28 UPLOAD filename1.pdf 0000000000-23-009459 44848
2023-08-11 10-Q 10-Q 0000950170-23-041590 001-37722 231161488 34 13684124 1 1
2023-08-11 8-K 8-K 2.02,9.01 0000950170-23-041586 001-37722 231161483 34 471859 1 1
2023-08-11 8-K 8-K 1.02 0001193125-23-209727 001-37722 231161482 34 148060 1 1
2023-08-08 PRE 14A PRE 14A 0001193125-23-205262 001-37722 231149125 34 1892144
2023-08-07 S-3 S-3 0001193125-23-205011 333-273769 231147951 33 2242641
2023-07-28 SC 13G polar-agle071923.htm 0001172661-23-002651 005-89456 231120373 34 110057
2023-07-27 8-K 8-K 1.01,1.02,2.01,7.01,8.01,9.01 0001193125-23-195289 001-37722 231115242 34 179318 1 1
2023-07-18 SC 13G agle13g.htm 0000935836-23-000523 005-89456 231094249 34 61427
2023-07-14 8-K 8-K 3.01 0001193125-23-187257 001-37722 231089176 34 184203 1 1
2023-07-10 SC 13G SC 13G 0001104659-23-079663 005-89456 231079916 34 175736
2023-07-06 D xslFormDX01/primary_doc.xml 06b 0001231919-23-000044 021-486102 231073584 33 19550
2023-07-03 SC 13G ACQUISITION OF BENEFICIAL OWNERSHIP 0001839882-23-017505 005-89456 231065465 34 98520
2023-06-30 3 3 0000950170-23-031185 20706
2023-06-30 SC 13D SC 13D 0001193125-23-180612 005-89456 231062842 34 147416
2023-06-30 3 3 0000950170-23-031168 14859
2023-06-30 3 3 0000950170-23-031167 12735
2023-06-30 4 FORM 4 SUBMISSION 0001209191-23-040338 5833
2023-06-30 4 FORM 4 SUBMISSION 0001209191-23-040335 5796
2023-06-30 4 FORM 4 SUBMISSION 0001209191-23-040333 5971
2023-06-30 4 FORM 4 SUBMISSION 0001209191-23-040329 5768
2023-06-30 4 FORM 4 SUBMISSION 0001209191-23-040328 5842
2023-06-30 SC 13G agle13g.htm 0000935836-23-000494 005-89456 231062021 34 47226
2023-06-30 SC 13G deeptrack-agle062223.htm 0001172661-23-002388 005-89456 231061552 34 105717
2023-06-23 8-K 8-K 1.01,2.01,3.02,5.02,5.03,7.01,9.01 0001193125-23-173242 001-37722 231035065 34 8235632 1 1
2023-06-22 8-K 8-K 8.01,9.01 0001193125-23-172698 001-37722 231034220 34 193964 1 1
2023-06-09 8-K 8-K 5.07 0001193125-23-164444 001-37722 231005282 34 163175 1 1
2023-05-19 DEFA14A DEFA14A 0001193125-23-149311 001-37722 23940116 34 11473
2023-05-19 8-K 8-K 5.02 0001193125-23-149301 001-37722 23940059 34 147258 1 1
2023-05-11 10-Q 10-Q 0000950170-23-020825 001-37722 23908762 34 7514388 1 1
2023-05-11 8-K 8-K 2.02,9.01 0000950170-23-020819 001-37722 23908746 34 471172 1 1
2023-04-25 8-K 8-K 2.02,7.01,9.01 0001193125-23-115402 001-37722 23845293 34 15739817 1 1
2023-04-17 ARS ARS 0001193125-23-103763 001-37722 23824538 34 773156
2023-04-17 DEF 14A DEF 14A 0001193125-23-103731 001-37722 23824483 34 983960
2023-04-12 8-K 8-K 2.05,5.02,8.01,9.01 0001193125-23-098539 001-37722 23814739 34 184307 1 1
2023-04-07 PRE 14A PRE 14A 0001193125-23-095201 001-37722 23808798 34 983736
2023-03-13 8-K 8-K 8.01 0001193125-23-068397 001-37722 23725577 34 148057 1 1
2023-03-02 S-8 S-8 0001193125-23-057310 333-270208 23696463 33 90136
2023-03-02 424B5 424B5 0001193125-23-057268 333-239706 23696410 33 119462
2023-03-02 10-K 10-K 0000950170-23-005705 001-37722 23696398 34 15286070 1 1
2023-03-02 8-K 8-K 2.02,7.01,9.01 0000950170-23-005699 001-37722 23696384 34 20084437 1 1
2023-02-24 4 FORM 4 SUBMISSION 0001209191-23-012882 5533
2023-02-24 4 FORM 4 SUBMISSION 0001209191-23-012881 5499
2023-02-24 4 FORM 4 SUBMISSION 0001209191-23-012877 5550
2023-02-24 4 FORM 4 SUBMISSION 0001209191-23-012875 5541
2023-02-14 SC 13G/A SC 13G/A 0001104659-23-021874 005-89456 23631026 34 56541
2023-02-14 SC 13G/A AMENDMENT NO. 6 0000947871-23-000163 005-89456 23628475 34 58447
2023-02-14 SC 13G SC 13G 0001104659-23-021466 005-89456 23628436 34 126183
2023-02-14 SC 13G rocksprings-agle123122.htm 0001172661-23-001246 005-89456 23627512 34 88916
2023-02-14 SC 13G/A SC 13G/A 0001193125-23-036871 005-89456 23621740 34 45004
2023-02-13 SC 13G/A d9082020_13g-a.htm 0000919574-23-000935 005-89456 23614946 34 109929
2023-02-03 SC 13G SC 13G 0001193125-23-023699 005-89456 23584487 34 34945
2023-01-27 4 FORM 4 SUBMISSION 0001209191-23-005351 5585
2023-01-27 3 FORM 3 SUBMISSION 0001209191-23-005349 12229
2023-01-18 8-K 8-K 3.01 0000950170-23-000840 001-37722 23532900 34 173049 1 1
2023-01-10 SC 13G/A AGLE_SC13GA1_2023.htm 0001319244-23-000001 005-89456 23521577 34 95695
2023-01-09 8-K 8-K 7.01,9.01 0001193125-23-004150 001-37722 23516576 34 16064471 1 1
2023-01-06 8-K 8-K 5.02 0001193125-23-002979 001-37722 23513755 34 145942 1 1
2022-12-19 8-K 8-K 5.03,9.01 0001193125-22-308316 001-37722 221471116 34 355221 1 1
2022-12-01 4 FORM 4 SUBMISSION 0001209191-22-059262 5588
2022-12-01 3 FORM 3 SUBMISSION 0001209191-22-059261 6063
2022-12-01 SC 13G AGLE_SC13G.htm 0001319244-22-000177 005-89456 221438906 34 95662
2022-11-30 8-K 8-K 5.02 0001193125-22-294899 001-37722 221434294 34 151114 1 1
2022-11-15 8-K 8-K 8.01 0001193125-22-285197 001-37722 221389237 34 143814 1 1
2022-11-03 10-Q 10-Q 0000950170-22-021529 001-37722 221356147 34 9557365 1 1
2022-11-03 8-K 8-K 2.02,7.01,9.01 0000950170-22-021527 001-37722 221356132 34 4391819 1 1
2022-10-04 8-K 8-K 8.01 0001193125-22-257184 001-37722 221289710 34 148946 1 1
2022-09-06 8-K 8-K 7.01,9.01 0001193125-22-239029 001-37722 221228934 34 16404841 1 1
2022-08-25 4 FORM 4 SUBMISSION 0001209191-22-047656 5851
2022-08-25 3 FORM 3 SUBMISSION 0001209191-22-047655 9230
2022-08-25 4 FORM 4 SUBMISSION 0001209191-22-047653 4513
2022-08-25 4 FORM 4 SUBMISSION 0001209191-22-047651 5839
2022-08-25 4 FORM 4 SUBMISSION 0001209191-22-047649 5884
2022-08-25 4 FORM 4 SUBMISSION 0001209191-22-047648 5875
2022-08-25 8-K 8-K 5.02,8.01 0001193125-22-229043 001-37722 221192891 34 165852 1 1
2022-08-18 8-K 8-K 8.01 0001193125-22-224107 001-37722 221177550 34 151211 1 1
2022-08-04 10-Q 10-Q 0001564590-22-027895 001-37722 221134453 34 9106395 1 1
2022-08-04 8-K 8-K 2Q22 2.02,7.01,9.01 0001564590-22-027893 001-37722 221134432 34 11099383 1 1
2022-07-19 8-K 8-K 3.01 0001193125-22-196966 001-37722 221091629 34 151268 1 1
2022-07-07 8-K 8-K 5.02 0001193125-22-189446 001-37722 221071728 34 143158 1 1

Latest XBRL company facts

One latest value per concept from companyfacts (350 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 94.97M 2026-10-27 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
dei EntityPublicFloat Entity Public Float USD 1.10B 2025-06-30 2025 FY 10-K 2026-02-19 0001636282-26-000020
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 3.14M 2025-01-01 2025-12-31 DEF 14A 2026-04-10 0001636282-26-000039
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 2.20M 2025-01-01 2025-12-31 DEF 14A 2026-04-10 0001636282-26-000039
ecd PeerGroupTotalShareholderRtnAmt PeerGroupTotalShareholderRtnAmt USD 124.75 2025-01-01 2025-12-31 DEF 14A 2026-04-10 0001636282-26-000039
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 16.65 2025-01-01 2025-12-31 DEF 14A 2026-04-10 0001636282-26-000039
ffd NetFeeAmt NetFeeAmt USD 35,017.51 2026-10-06 424B5 2026-10-06 0001628280-26-065249
ffd TtlFeeAmt TtlFeeAmt USD 35,017.51 2026-10-06 424B5 2026-10-06 0001628280-26-065249
ffd TtlOfferingAmt TtlOfferingAmt USD 402.50M 2026-10-06 424B5 2026-10-06 0001628280-26-065249
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-06 424B5 2026-10-06 0001628280-26-065249
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-10-06 424B5 2026-10-06 0001628280-26-065249
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 2.85M 2023-06-30 2023 Q2 10-Q 2023-08-11 0000950170-23-041590
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 15.53M 2024-03-31 2024 Q1 10-Q/A 2024-11-18 0001636282-24-000109
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 20.81M 2023-06-30 2023 Q2 10-Q 2023-08-11 0000950170-23-041590
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 5.17M 2024-09-30 2024 Q3 10-Q/A 2024-11-18 0001636282-24-000113
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD 9.49M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap AccruedLiabilitiesAndOtherLiabilities Accrued Liabilities and Other Liabilities USD 30.59M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 2.34M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap AccruedSalariesCurrent Accrued Salaries, Current USD 7.34M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 0 2023-12-31 2023 FY 10-K/A 2024-11-18 0001636282-24-000107
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -5.38M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 250.30M 2019-03-31 2019 Q1 10-Q 2019-05-07 0001564590-19-016211
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 2.24B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 2.49M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005404
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 14.46M 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 800,000 2020-04-01 2020-04-30 2020 Q3 10-Q 2020-11-05 0001564590-20-050906
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 40.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap AreaOfLand Area of Land sqft 30,000 2019-04-30 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap AssetAcquisitionConsiderationTransferred AssetAcquisitionConsiderationTransferred USD 113.20M 2023-06-22 2023 Q3 10-Q 2023-11-09 0001636282-23-000018
us-gaap AssetAcquisitionConsiderationTransferredTransactionCost AssetAcquisitionConsiderationTransferredTransactionCost USD 3.20M 2023-06-22 2023 Q2 10-Q 2023-08-11 0000950170-23-041590
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap Assets Assets USD 1.10B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap AssetsCurrent Assets, Current USD 1.10B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 1.06B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap AssetsFairValueDisclosureRecurring Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) USD 40.34M 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011484
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 12,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 5.39M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 994.56M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap AvailableForSaleSecurities Available-for-sale Securities USD 50.20M 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028293
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax USD 4,000 2016-09-30 2016 Q3 10-Q 2016-11-09 0001564590-16-028480
us-gaap AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax USD 17,000 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054228
us-gaap AvailableForSaleSecuritiesAmortizedCost Available-for-sale Securities, Amortized Cost Basis USD 32.81M 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011484
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value USD 52.79M 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054228
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 17,000 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054228
us-gaap AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value USD 52.79M 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054228
us-gaap AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five USD 229.92M 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One USD 688.10M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap AvailableForSaleSecuritiesDebtSecurities Debt Securities, Available-for-sale USD 52.70M 2019-12-31 2019 FY 10-K 2020-02-24 0001564590-20-005888
us-gaap AvailableForSaleSecuritiesDebtSecuritiesCurrent Debt Securities, Available-for-sale, Current USD 989.18M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap BilledContractReceivables Billed Contracts Receivable USD 2.40M 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028293
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 2.07M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0000950170-23-041590
us-gaap CapitalUnitsAuthorized Capital Units, Authorized shares 510.00M 2016-04-12 2017 Q3 10-Q 2017-11-07 0001564590-17-022228
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 82.73M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap CashAndCashEquivalentsFairValueDisclosure Cash and Cash Equivalents, Fair Value Disclosure USD 71.85M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 7.76M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001564590-18-020760
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 1.10B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 82.73M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations USD 236.68M 2023-06-30 2023 Q2 10-Q 2023-08-11 0000950170-23-041590
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -2.99M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 71.85M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.003 2022-05-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 694,892 2022-05-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 0 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 400.00M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 89.95M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 89.95M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap CommonStockValue Common Stock, Value, Issued USD 16,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -207.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap ContractWithCustomerAssetNet Contract with Customer, Asset, after Allowance for Credit Loss USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 0 2023-12-31 2023 FY 10-K/A 2024-11-18 0001636282-24-000107
us-gaap ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination USD -3.27M 2023-01-01 2023-12-31 2023 FY 10-K/A 2024-11-18 0001636282-24-000107
us-gaap ContractWithCustomerLiabilityNoncurrent Contract with Customer, Liability, Noncurrent USD 0 2023-12-31 2023 FY 10-K/A 2024-11-18 0001636282-24-000107
us-gaap ContractWithCustomerLiabilityRevenueRecognized Contract with Customer, Liability, Revenue Recognized USD 21.50M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-04 0001564590-21-054228
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 9.39M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap ConversionOfStockAmountIssued1 Conversion of Stock, Amount Issued USD 202.18M 2023-01-01 2023-12-31 2023 FY 10-K/A 2024-11-18 0001636282-24-000107
us-gaap DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss USD 4.50M 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest DebtSecuritiesAvailableForSaleAmortizedCostAllowanceForCreditLossExcludingAccruedInterest USD 0 2024-12-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months USD 932.77M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 5.39M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap DebtSecuritiesAvailableForSaleRealizedGainLoss Debt Securities, Available-for-sale, Realized Gain (Loss) USD 300,000 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap DebtSecuritiesAvailableForSaleUnrealizedGainLoss Debt Securities, Available-for-sale, Unrealized Gain (Loss) USD 700,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPosition Debt Securities, Available-for-sale, Unrealized Loss Position USD 932.77M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss USD 5.39M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions Security 38 2022-06-30 2022 Q2 10-Q 2022-08-04 0001564590-22-027895
us-gaap DecreaseInRestrictedCash Decrease in Restricted Cash USD 80,000 2016-01-01 2016-09-30 2017 Q3 10-Q 2017-11-07 0001564590-17-022228
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 183,000 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 2.54M 2015-12-31 2016 FY 10-K 2017-03-23 0001564590-17-005137
us-gaap DeferredRevenueCurrent Deferred Revenue, Current USD 930,000 2023-06-30 2023 Q2 10-Q 2023-08-11 0000950170-23-041590
us-gaap DeferredRevenueNoncurrent Deferred Revenue, Noncurrent USD 2.34M 2023-06-30 2023 Q2 10-Q 2023-08-11 0000950170-23-041590
us-gaap DeferredTaxAssetsDeferredIncome Deferred Tax Assets, Deferred Income USD 0 2024-12-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 4.07M 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 201.53M 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 118.51M 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 87,000 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 12.94M 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 1.63M 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 201.34M 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2024-12-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities Deferred Tax Liabilities, Unrealized Gains on Trading Securities USD 183,000 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap DefinedContributionPlanCostRecognized Defined Contribution Plan, Cost USD 800,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap DefinedContributionPlanEmployerDiscretionaryContributionAmount Defined Contribution Plan, Employer Discretionary Contribution Amount USD 600,000 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -1.44M 2014-01-01 2014-12-31 2016 FY 10-K 2017-03-23 0001564590-17-005137
us-gaap DerivativeLiabilities Derivative Liability USD 6.76M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 0 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 6.76M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap DisposalGroupIncludingDiscontinuedOperationConsideration Disposal Group, Including Discontinued Operation, Consideration USD 500,000 2023-06-30 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap DisposalGroupNotDiscontinuedOperationGainLossOnDisposal Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal USD 70.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap Dividends Dividends USD 0 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-23 0001564590-17-005137
us-gaap DividendsCommonStock Dividends, Common Stock USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 2.39 2024-01-01 2024-09-30 2024 Q3 10-Q/A 2024-11-18 0001636282-24-000113
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.37 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0001564590-22-018006
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -2.04 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.242 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent pure -0.005 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure -0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.001 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD -2.52M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent pure 0.016 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense Share-based Payment Arrangement, Expense, Tax Benefit USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ExpenseRelatedToDistributionOrServicingAndUnderwritingFees Expense Related to Distribution or Servicing and Underwriting Fees USD 8.20M 2020-04-01 2020-04-30 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap FairValueAssetsLevel1ToLevel2TransfersAmount Fair Value, Assets, Level 1 to Level 2 Transfers, Amount USD 0 2021-12-31 2021 FY 10-K 2022-03-08 0001564590-22-008995
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.7 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005404
us-gaap FairValueInputsDiscountRate Fair Value Inputs, Discount Rate (Deprecated 2018-01-31) pure 0.3 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005404
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 0 2022-12-31 2023 Q3 10-Q 2023-11-09 0001636282-23-000018
us-gaap FinanceLeaseLiability Finance Lease, Liability USD 16,000 2022-12-31 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap FinanceLeaseLiabilityCurrent Finance Lease, Liability, Current USD 0 2023-12-31 2023 FY 10-K/A 2024-11-18 0001636282-24-000107
us-gaap FinanceLeaseLiabilityNoncurrent Finance Lease, Liability, Noncurrent USD 16,000 2021-12-31 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap FinanceLeaseLiabilityPaymentsDue Finance Lease, Liability, Payment, Due USD 16,000 2022-12-31 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap FinanceLeaseLiabilityPaymentsDueNextTwelveMonths Finance Lease, Liability, to be Paid, Year One USD 16,000 2022-12-31 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap FinanceLeaseLiabilityPaymentsDueYearThree Finance Lease, Liability, to be Paid, Year Three USD 17,000 2020-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014021
us-gaap FinanceLeaseLiabilityPaymentsDueYearTwo Finance Lease, Liability, to be Paid, Year Two USD 16,000 2021-12-31 2021 FY 10-K 2022-03-08 0001564590-22-008995
us-gaap FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear Finance Lease, Liability, to be Paid, Remainder of Fiscal Year USD 9,000 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-040692
us-gaap FinanceLeaseLiabilityUndiscountedExcessAmount Finance Lease, Liability, Undiscounted Excess Amount USD 6,000 2021-12-31 2021 FY 10-K 2022-03-08 0001564590-22-008995
us-gaap FinanceLeasePrincipalPayments Finance Lease, Principal Payments USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap FinanceLeaseRightOfUseAsset Finance Lease, Right-of-Use Asset, after Accumulated Amortization USD 0 2023-12-31 2023 FY 10-K/A 2024-11-18 0001636282-24-000107
us-gaap FinanceLeaseWeightedAverageDiscountRatePercent Finance Lease, Weighted Average Discount Rate, Percent pure 0 2023-12-31 2023 FY 10-K/A 2024-11-18 0001636282-24-000107
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 0 2022-12-31 2023 FY 10-K/A 2024-11-18 0001636282-24-000107
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD -35.81M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 47.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap GrantsReceivableCurrent Grants Receivable, Current USD 3.08M 2017-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006771
us-gaap HeldToMaturitySecuritiesContinuousUnrealizedLossPositionAccumulatedLoss Debt Securities, Held-to-maturity, Unrealized Loss Position, Accumulated Loss USD 34,000 2022-12-31 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap HeldToMaturitySecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss Debt Securities, Held-to-maturity, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss USD 34,000 2022-12-31 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap ImpairmentOfLeasehold Impairment of Leasehold USD 1.70M 2023-06-30 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -155.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -201.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 37,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncomeLossFromEquityMethodInvestments Income (Loss) from Equity Method Investments USD -83.95M 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD -15,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncomeTaxExaminationPenaltiesAndInterestExpense Income Tax Examination, Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap IncomeTaxPaidFederalAfterRefundReceived IncomeTaxPaidFederalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncomeTaxPaidForeignAfterRefundReceived IncomeTaxPaidForeignAfterRefundReceived USD -15,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncomeTaxPaidStateAndLocalAfterRefundReceived IncomeTaxPaidStateAndLocalAfterRefundReceived USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 37.62M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 1.86M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD -23,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -32.60M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopment Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Amount USD 0 2024-01-01 2024-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 773,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD 10,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 114,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 2.04M 2023-01-01 2023-06-30 2023 Q2 10-Q 2023-08-11 0000950170-23-041590
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD 562,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 4.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap IncreaseDecreaseInContractWithCustomerLiability Increase (Decrease) in Contract with Customer, Liability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncreaseDecreaseInDeferredCharges Increase (Decrease) in Deferred Charges USD -5,000 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-09 0001564590-17-009615
us-gaap IncreaseDecreaseInDeferredRevenue Increase (Decrease) in Deferred Revenue USD -20,000 2018-01-01 2018-09-30 2018 Q3 10-Q 2018-11-08 0001564590-18-028293
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap IncreaseDecreaseInOtherAccountsPayable Increase (Decrease) in Other Accounts Payable USD 68,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD 5.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap IncreaseDecreaseInRestrictedCash Increase (Decrease) in Restricted Cash USD -80,000 2016-01-01 2016-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006771
us-gaap IncreaseDecreaseInSecurityDeposits Increase (Decrease) in Security Deposits USD -18,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-09 0001564590-16-028480
us-gaap IncreaseInRestrictedCash Increase in Restricted Cash USD 75,000 2016-01-01 2016-06-30 2017 Q2 10-Q 2017-08-09 0001564590-17-016937
us-gaap IncrementalCommonSharesAttributableToCallOptionsAndWarrants Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants shares 116,788 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001636282-24-000083
us-gaap InterestCostsIncurred Interest Costs Incurred USD 0 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-08 0001564590-22-008995
us-gaap InvestmentIncomeAmortizationOfPremium Investment Income, Amortization of Premium USD 75,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005404
us-gaap InvestmentIncomeNet Investment Income, Net USD 27.67M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap InvestmentIncomeNetAmortizationOfDiscountAndPremium Investment Income, Net, Amortization of Discount and Premium USD 593,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006771
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 107,000 2018-01-01 2018-12-31 2020 FY 10-K 2021-03-18 0001564590-21-014021
us-gaap LeaseCost Lease, Cost USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 6.07M 2022-12-31 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive Lessee, Operating Lease, Liability, to be Paid, after Year Five USD 403,000 2022-12-31 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 1.08M 2022-12-31 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 1.20M 2022-12-31 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 1.16M 2022-12-31 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 1.13M 2022-12-31 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 1.10M 2022-12-31 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 169,000 2019-09-30 2019 Q3 10-Q 2019-11-06 0001564590-19-040692
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 1.45M 2022-12-31 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap Liabilities Liabilities USD 48.19M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 1.10B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap LiabilitiesCurrent Liabilities, Current USD 40.14M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap LiabilitiesFairValueDisclosure Financial and Nonfinancial Liabilities, Fair Value Disclosure USD 6.76M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap MarketableSecurities Marketable Securities USD 486.20M 2025-09-30 2025 Q3 10-Q 2025-11-04 0001636282-25-000102
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 38.07M 2019-03-31 2019 Q1 10-Q 2019-05-07 0001564590-19-016211
us-gaap MarketableSecuritiesRealizedGainLoss Marketable Securities, Realized Gain (Loss) USD 0 2018-01-01 2018-12-31 2019 FY 10-K 2020-02-24 0001564590-20-005888
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 446.88M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 38.75M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001564590-18-020760
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -245.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD -14.50M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001564590-18-020760
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -204.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -16.49M 2018-01-01 2018-06-30 2018 Q2 10-Q 2018-08-09 0001564590-18-020760
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -201.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -27.24M 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005404
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD -8.33M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap NontradeReceivablesCurrent Nontrade Receivables, Current USD 0 2023-12-31 2023 FY 10-K/A 2024-11-18 0001636282-24-000107
us-gaap NumberOfOperatingSegments Number of Operating Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap NumberOfReportableSegments Number of Reportable Segments segment 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap OperatingExpenses Operating Expenses USD 193.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -193.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap OperatingLeaseCost Operating Lease, Cost USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap OperatingLeaseExpense Operating Lease, Expense USD 1.30M 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-24 0001564590-20-005888
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 900,000 2023-06-30 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 4.63M 2022-12-31 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 0 2023-12-31 2023 FY 10-K/A 2024-11-18 0001636282-24-000107
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2023-12-31 2023 FY 10-K/A 2024-11-18 0001636282-24-000107
us-gaap OperatingLeasePayments Operating Lease, Payments USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2023-12-31 2023 FY 10-K/A 2024-11-18 0001636282-24-000107
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 889,000 2018-12-31 2019 FY 10-K 2020-02-24 0001564590-20-005888
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 397,000 2018-12-31 2019 FY 10-K 2020-02-24 0001564590-20-005888
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFiveYears Operating Leases, Future Minimum Payments, Due in Five Years USD 301,000 2016-09-30 2016 Q3 10-Q 2016-11-09 0001564590-16-028480
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 300,000 2017-03-31 2017 Q1 10-Q 2017-05-09 0001564590-17-009615
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 83,000 2018-12-31 2019 FY 10-K 2020-02-24 0001564590-20-005888
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 409,000 2018-12-31 2019 FY 10-K 2020-02-24 0001564590-20-005888
us-gaap OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear Operating Leases, Future Minimum Payments, Remainder of Fiscal Year USD 314,000 2017-03-31 2017 Q1 10-Q 2017-05-09 0001564590-17-009615
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 400,000 2018-01-01 2018-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006771
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0 2023-12-31 2023 FY 10-K/A 2024-11-18 0001636282-24-000107
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 560.10M 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 144,000 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax USD -6.25M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 1.29M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap OtherNoncashIncomeExpense Other Noncash Income (Expense) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -36.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap OtherSignificantNoncashTransactionValueOfConsiderationGiven1 Other Significant Noncash Transaction, Value of Consideration Given USD 232,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005404
us-gaap PartnersCapitalAccountDistributions Partners' Capital Account, Distributions USD 0 2015-03-09 2015-03-10 2017 FY 10-K 2018-03-13 0001564590-18-005404
us-gaap PaymentForContingentConsiderationLiabilityFinancingActivities Payment for Contingent Consideration Liability, Financing Activities USD 5.25M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap PaymentsForDerivativeInstrumentFinancingActivities Payments for Derivative Instrument, Financing Activities USD 1.43M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap PaymentsForRestructuring Payments for Restructuring USD 5.30M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 800,000 2020-04-01 2020-04-30 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap PaymentsToAcquireAvailableForSaleSecuritiesDebt Payments to Acquire Debt Securities, Available-for-sale USD 666.79M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 19.75M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-07 0001564590-19-016211
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap PreferredStockDividendRatePercentage Preferred Stock, Dividend Rate, Percentage pure 0.08 2016-01-01 2016-12-31 2016 FY 10-K 2017-03-23 0001564590-17-005137
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2024-03-31 2024 Q1 10-Q/A 2024-11-18 0001636282-24-000109
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2024-03-31 2024 Q1 10-Q/A 2024-11-18 0001636282-24-000109
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2023-09-30 2023 Q3 10-Q 2023-11-09 0001636282-23-000018
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 27.82M 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 42.90M 2022-05-01 2022-05-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 169.21M 2024-01-01 2024-03-31 2024 Q1 10-Q/A 2024-11-18 0001636282-24-000109
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 435.24M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions Proceeds, Issuance of Shares, Share-based Payment Arrangement, Including Option Exercised USD 28.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 96,000 2017-01-01 2017-03-31 2017 Q1 10-Q 2017-05-09 0001564590-17-009615
us-gaap ProceedsFromPaymentsForOtherFinancingActivities Proceeds from (Payments for) Other Financing Activities USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities Proceeds from Sale and Maturity of Debt Securities, Available-for-sale USD 351.66M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 33.80M 2019-01-01 2019-03-31 2019 Q1 10-Q 2019-05-07 0001564590-19-016211
us-gaap ProceedsFromSaleOfIntangibleAssets Proceeds from Sale of Intangible Assets USD 70.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ProceedsFromStockPlans Proceeds from Stock Plans USD 76,000 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-09 0001564590-16-028480
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-24 0001564590-20-005888
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -151.72M 2024-01-01 2024-09-30 2024 Q3 10-Q/A 2024-11-18 0001636282-24-000113
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 0 2023-12-31 2023 FY 10-K/A 2024-11-18 0001636282-24-000107
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 0 2023-12-31 2023 FY 10-K/A 2024-11-18 0001636282-24-000107
us-gaap ReceivablesNetCurrent Receivables, Net, Current USD 21.50M 2021-03-31 2021 Q1 10-Q 2021-05-10 0001564590-21-025791
us-gaap ReimbursementFromLimitedPartnershipInvestment Reimbursement from Limited Partnership Investment USD 3.00M 2021-01-01 2021-12-31 2021 FY 10-K 2022-03-08 0001564590-22-008995
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 13.78M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-11 0000950170-23-020825
us-gaap ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost Research and Development Expense (Excluding Acquired in Process Cost) USD 215.08M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap RestrictedCash Restricted Cash USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 80,000 2015-12-31 2016 FY 10-K 2017-03-23 0001564590-17-005137
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent Restructuring and Related Cost, Number of Positions Eliminated, Period Percent pure 0.83 2023-04-12 2023-06-30 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -1.33B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap RevenueFromContractWithCustomerIncludingAssessedTax Revenue from Contract with Customer, Including Assessed Tax USD 0 2021-01-01 2021-03-31 2021 Q1 10-Q 2021-05-10 0001564590-21-025791
us-gaap RevenueFromGrants Revenue from Grants (Deprecated 2018-01-31) USD 1.51M 2018-01-01 2018-03-31 2018 Q1 10-Q 2018-05-08 0001564590-18-011484
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 4.75 2020-04-30 2020 Q3 10-Q 2020-11-05 0001564590-20-050906
us-gaap SecurityDeposit Security Deposit USD 1.50M 2019-04-30 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap SecurityDepositLiability Security Deposit Liability USD 48,000 2018-12-31 2018 FY 10-K 2019-03-07 0001564590-19-006771
us-gaap SeveranceCosts1 Severance Costs USD 6.40M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 40.48M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost Share-based Payment Arrangement, Accelerated Cost USD 1.00M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period shares 38,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 0.87 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-19 0001564590-16-019683
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.013 2016-01-01 2016-03-31 2016 Q1 10-Q 2016-05-19 0001564590-16-019683
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 95.15M 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 5.16M 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 14.5 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 198,455 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 2.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 191.20M 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 11.37M 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 16.06 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 191.20M 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 11.37M 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 16.06 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationNumberOfEmployeesAffected Share-based Payment Arrangement, Plan Modification, Number of Grantees Affected Employee 7 2015-03-09 2015-03-10 2017 FY 10-K 2018-03-13 0001564590-18-005404
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 8.68 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 33.38 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 34.81 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 1.05B 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap StockholdersEquityNoteStockSplitConversionRatio1 Stockholders' Equity Note, Stock Split, Conversion Ratio pure 0.095 2017-01-01 2017-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005404
us-gaap StockIssued1 Stock Issued USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 307,673 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 189.74M 2023-01-01 2023-12-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 0 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap StockIssuedDuringPeriodValueEmployeeStockPurchasePlan Stock Issued During Period, Value, Employee Stock Purchase Plan USD 222,000 2022-01-01 2022-12-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 29.52M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 3.77M 2023-01-01 2023-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 14.17M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-03 0001636282-26-000131
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 1.45M 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-02 0000950170-23-005705
us-gaap TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit) USD 0 2019-01-01 2019-12-31 2019 FY 10-K 2020-02-24 0001564590-20-005888
us-gaap TemporaryEquityAggregateAmountOfRedemptionRequirement Temporary Equity, Aggregate Amount of Redemption Requirement USD 129.10M 2023-12-31 2023 FY 10-K/A 2024-11-18 0001636282-24-000107
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 0 2024-12-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap TemporaryEquityDividendsAdjustment Temporary Equity, Dividends, Adjustment USD 228,000 2015-01-01 2015-12-31 2017 FY 10-K 2018-03-13 0001564590-18-005404
us-gaap TemporaryEquityParOrStatedValuePerShare Temporary Equity, Par or Stated Value Per Share USD/shares 0 2023-12-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap TemporaryEquityRedemptionPricePerShare Temporary Equity, Redemption Price Per Share USD/shares 21.52 2023-12-31 2023 FY 10-K/A 2024-11-18 0001636282-24-000107
us-gaap TemporaryEquitySharesAuthorized Temporary Equity, Shares Authorized shares 150,000 2023-12-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 150,000 2023-12-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap TemporaryEquitySharesOutstanding Temporary Equity, Shares Outstanding shares 0 2024-12-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap TemporaryEquityStockIssuedDuringPeriodValueNewIssues Temporary Equity, Stock Issued During Period, Value, New Issues USD 168.85M 2024-01-01 2024-12-31 2024 FY 10-K 2025-02-27 0001636282-25-000020
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 120,000 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0001564590-22-018006
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-09 0001564590-16-028480
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 38.40M 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap VariableLeaseCost Variable Lease, Cost USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-02-19 0001636282-26-000020
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 44.26M 2024-01-01 2024-09-30 2024 Q3 10-Q/A 2024-11-18 0001636282-24-000113
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 66.00M 2022-01-01 2022-03-31 2022 Q1 10-Q 2022-05-05 0001564590-22-018006
us-gaap WeightedAverageNumberOfSharesIssuedBasic Weighted Average Number of Shares Issued, Basic shares 44.15M 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-07 0001636282-24-000083
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 44.26M 2024-01-01 2024-09-30 2024 Q3 10-Q/A 2024-11-18 0001636282-24-000113

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →